PT SARANA MEDITAMA METROPOLITAN TBK Financials PT Sarana Meditama Metropolitan Tbk
Equities
SAME
ID1000126303
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248 IDR | -0.80% |
|
-0.80% | -21.02% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,304,000 | 1,475,000 | 1,722,800 | 6,337,964 | 5,138,890 | 5,381,452 |
| Enterprise Value (EV) 1 | 4,226,261 | 2,517,564 | 2,747,977 | 5,757,079 | 5,567,330 | 6,194,890 |
| P/E ratio | 56.1 x | -12.9 x | -3.83 x | 36.2 x | 1,182 x | 439 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.47 x | 2.79 x | 3.39 x | 4.98 x | 3.69 x | 3.5 x |
| EV / Revenue | 4.44 x | 4.76 x | 5.41 x | 4.53 x | 4 x | 4.03 x |
| EV / EBITDA | 15.5 x | 29.4 x | 25.8 x | 17 x | 23.4 x | 23.2 x |
| EV / FCF | -7.95 x | -42.4 x | 27.7 x | 81.6 x | -58.8 x | -15.7 x |
| FCF Yield | -12.6% | -2.36% | 3.62% | 1.23% | -1.7% | -6.38% |
| Price to Book | 2.49 x | 1.51 x | 3.16 x | 1.65 x | 1.42 x | 1.48 x |
| Nbr of stocks (in thousands) | 5,900,000 | 5,900,000 | 5,900,000 | 17,129,633 | 17,129,633 | 17,138,383 |
| Reference price 2 | 560.0 | 250.0 | 292.0 | 370.0 | 300.0 | 314.0 |
| Announcement Date | 29/03/19 | 13/03/20 | 01/04/21 | 05/04/22 | 31/03/23 | 28/03/24 |
1IDR in Million2IDR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 952,082 | 529,320 | 507,617 | 1,271,584 | 1,393,542 | 1,535,640 |
| EBITDA 1 | 272,091 | 85,626 | 106,350 | 338,736 | 237,416 | 267,457 |
| EBIT 1 | 175,639 | 5,411 | 10,885 | 188,958 | 34,177 | 46,952 |
| Operating Margin | 18.45% | 1.02% | 2.14% | 14.86% | 2.45% | 3.06% |
| Earnings before Tax (EBT) 1 | 81,699 | -140,271 | -374,982 | 136,614 | 17,225 | 13,007 |
| Net income 1 | 58,883 | -114,385 | -449,464 | 138,554 | 4,347 | 12,252 |
| Net margin | 6.18% | -21.61% | -88.54% | 10.9% | 0.31% | 0.8% |
| EPS 2 | 9.980 | -19.39 | -76.18 | 10.23 | 0.2538 | 0.7150 |
| Free Cash Flow 1 | -531,656 | -59,334 | 99,365 | 70,565 | -94,707 | -395,052 |
| FCF margin | -55.84% | -11.21% | 19.57% | 5.55% | -6.8% | -25.73% |
| FCF Conversion (EBITDA) | - | - | 93.43% | 20.83% | - | - |
| FCF Conversion (Net income) | - | - | - | 50.93% | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 29/03/19 | 13/03/20 | 01/04/21 | 05/04/22 | 31/03/23 | 28/03/24 |
1IDR in Million2IDR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 922,261 | 1,042,564 | 1,025,177 | - | 428,440 | 813,437 |
| Net Cash position 1 | - | - | - | 580,885 | - | - |
| Leverage (Debt/EBITDA) | 3.39 x | 12.18 x | 9.64 x | - | 1.805 x | 3.041 x |
| Free Cash Flow 1 | -531,656 | -59,334 | 99,365 | 70,565 | -94,707 | -395,052 |
| ROE (net income / shareholders' equity) | 4.97% | -9.93% | -59% | 4.58% | 0.23% | 0.45% |
| ROA (Net income/ Total Assets) | 5.17% | 0.14% | 0.33% | 2.97% | 0.42% | 0.56% |
| Assets 1 | 1,138,188 | -80,552,664 | -136,201,318 | 4,659,622 | 1,026,501 | 2,192,983 |
| Book Value Per Share 2 | 225.0 | 166.0 | 92.50 | 224.0 | 211.0 | 212.0 |
| Cash Flow per Share 2 | 17.40 | 3.850 | 4.440 | 36.50 | 17.60 | 7.490 |
| Capex 1 | 489,662 | 369,364 | 6,730 | 139,041 | 166,203 | 456,921 |
| Capex / Sales | 51.43% | 69.78% | 1.33% | 10.93% | 11.93% | 29.75% |
| Announcement Date | 29/03/19 | 13/03/20 | 01/04/21 | 05/04/22 | 31/03/23 | 28/03/24 |
1IDR in Million2IDR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -21.02% | 265M | |
| -18.90% | 16.51B | |
| +4.50% | 12.53B | |
| +4.81% | 11.74B | |
| +2.43% | 10.06B | |
| -4.75% | 7.57B | |
| +21.11% | 7.22B | |
| +5.46% | 6.68B | |
| +45.72% | 4.54B | |
| -3.49% | 4.32B |
- Stock Market
- Equities
- SAME Stock
- Financials PT Sarana Meditama Metropolitan Tbk
